Koers Kazia Therapeutics Australian S.E.
Aandelen
KZA
AU000000KZA9
Biotechnologie & Medisch Onderzoek
Omzet 2022 | 10K 6,5K 6,07K | Omzet 2023 | 555 360,62 337,16 | Marktkapitalisatie | 39,72 mln. 25,81 mln. 24,13 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -24 mln. -15,59 mln. -14,58 mln. | Nettowinst (verlies) 2023 | -20 mln. -13 mln. -12,15 mln. | EV/omzet 2022 | 7.714 x |
Nettoliquiditeiten 2022 | 7,36 mln. 4,78 mln. 4,47 mln. | Nettoliquiditeiten 2023 | 3,44 mln. 2,24 mln. 2,09 mln. | EV/omzet 2023 | 65.355 x |
K/w-verhouding 2022 |
-3,27
x | K/w-verhouding 2023 |
-1,55
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 45,6% |
Recentste transcriptie over Kazia Therapeutics
Vaira. 1 jan. | Kapi. | |
---|---|---|
+5,14% | 43,43 mld. | |
+48,49% | 41,69 mld. | |
+9,28% | 41,31 mld. | |
-10,82% | 27,14 mld. | |
+10,57% | 25,28 mld. | |
-23,79% | 18,47 mld. | |
+36,62% | 12,59 mld. | |
+2,74% | 12,33 mld. | |
+8,28% | 11,03 mld. |